Related Experiment Video
Updated: Jul 3, 2026
10:35
Production and Testing of Antimicrobial Peptides and Their Mimics
Published on: April 10, 2026
Recent Progress in Antimicrobial Peptides (AMPs) Towards Enhanced Selectivity and Reduced Cytotoxicity by Molecular
Silvi Gautam1, Shagun Gautam2, Jahanvi Saini1
1Department of Microbiology, Graphic Era (Deemed to be University), Dehradun, Uttarakhand, India.
Biotechnology and Bioengineering
|July 1, 2026
Summary
Antimicrobial peptides (AMPs) offer a promising alternative to antibiotics due to their broad-spectrum activity and low resistance potential. Engineering AMPs enhances their effectiveness and safety for treating infections.
Area of Science:
- Biochemistry and Molecular Biology
- Drug Discovery and Development
- Microbiology
Background:
- Rising antimicrobial resistance necessitates novel therapeutic strategies beyond conventional antibiotics.
- Antimicrobial peptides (AMPs) show potential as broad-spectrum agents with rapid action and low resistance development.
- Engineering AMPs is crucial for optimizing their therapeutic efficacy and minimizing host cell toxicity.
Purpose of the Study:
- To review advancements in engineering antimicrobial peptides (AMPs).
- To explore AMP mechanisms of action, including membrane disruption and immune modulation.
- To outline design strategies and challenges for clinical AMP development.
Main Methods:
- Literature review synthesizing progress in AMP engineering.
- Analysis of AMP-lipid bilayer interactions and their mechanisms.
- Examination of physicochemical properties influencing AMP activity and compatibility.
Main Results:
- AMPs exert antimicrobial effects through membrane disruption, intracellular targeting, biofilm inhibition, and immune modulation.
- Physicochemical properties (charge, hydrophobicity), length, and secondary structure significantly impact AMP activity and host compatibility.
- Various engineering approaches, including modifications, mimetics, hybrids, and dendritic structures, are being explored.
Conclusions:
- Engineering AMPs holds significant promise for developing new antimicrobial therapies.
- Challenges remain in AMP stability, toxicity, delivery, and clinical translation.
- Further research into computational and bioengineering techniques is vital for AMP drug development.
Related Concept Videos
01:23Antimicrobial Proteins
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
01:25Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
01:25Inhibitors of Bacterial Protein Synthesis
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
01:25Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
00:57Antibiotic Selection
Overview
01:28Biological Methods for Microbial Control
Biological agents offer an effective means of controlling microbial growth by leveraging natural processes like predation, competition, and the secretion of antimicrobial substances.Predatory bacteria such as Bdellovibrio species target and kill pathogens like Salmonella and E. coli. They are widely used in poultry farms to control infections. Myxococcus species help combat plant-pathogenic fungi. These naturally occurring predators serve as eco-friendly alternatives to chemical pesticides and...